Molina Healthcare of Mississippi policies, page 12

Search Molina Healthcare of Mississippi's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

712 public policies Substrate tracks for Molina Healthcare of Mississippi, by title.

Molina Healthcare of Mississippi policies
PolicyDetailsCodesSource
Repeat Procedure Modifiers 76 & 77Medicaid · MS2Original policy ↗
Repeat Procedure Modifiers 76 77Commercial2Original policy ↗
Respiratory Pathogen Panel TestingEffective Sep 8, 2024 · Medicaid · MS—Original policy ↗
Respiratory Pathogen Panel Testing PolicyCommercial, Medicaid6Original policy ↗
Revcovi (elapegademase) MHIMedicaid · IL, MS1Original policy ↗
Reyvow (lasmiditan) MHIMedicaid · IL, MS—Original policy ↗
Rezurock (belumosudil) MHIMedicaid · IL, MS—Original policy ↗
Rezzayo (rezafungin) MHIMedicaid · MS1Original policy ↗
Riluzole (Rilutek_Tiglutik_Exservan) MHIMedicaid · IL, MS—Original policy ↗
Rinvoq (Upadacitinib) MHIMedicaid · MS—Original policy ↗
Rituxan (rituximab) and Biosimilars MHIMedicaid · IL, MS4Original policy ↗
Robotically Assisted SurgeryCommercial, Medicaid1Original policy ↗
Ryoncil (remestemcel)Commercial3Original policy ↗
Ryplazim (plasminogen, human) MHIMedicaid · IL, MS1Original policy ↗
Rystiggo (rozanolixizumab) MHIMedicaid · IL, MS1Original policy ↗
Santyl (collagenase) MHIMedicaid · IL, MS—Original policy ↗
Saphnelo (anifrolumab) MHIMedicaid · IL, MS1Original policy ↗
Savella (milnacipran) MHIMedicaid · IL, MS—Original policy ↗
Scenesse (afamelanotide) Implant367 · Commercial, Medicaid1Original policy ↗
Scenesse (afamelanotide) Implant: MEDICARE367b · Effective Apr 15, 20261Original policy ↗
Sclerotherapy and Adhesive Therapy for Varicose VeinsCommercial, Medicaid8Original policy ↗
Self Administered DrugsCommercial, Medicaid137Original policy ↗
Self Administered DrugsMedicaid · MS—Original policy ↗
Semiprivate Versus (Vs) Private RoomEffective Aug 19, 2025 · Commercial—Original policy ↗
Semiprivate Vs Private RoomMedicaid · MS—Original policy ↗
Sensipar (cinacalcet) MHIMedicaid · IL, MS—Original policy ↗
SepsisCommercial, Medicaid—Original policy ↗
SepsisEffective Jan 7, 2022 · Medicaid · MS—Original policy ↗
Serotonin-Norepinephrine Reuptake Inhibitors (SNRI) MHIMedicaid · IL, MS—Original policy ↗
Sexual Dysfunction Criteria- Non-Coverage MHIMedicaid · IL, MS4Original policy ↗
Seysara (sarecyline) MHIMedicaid · MS—Original policy ↗
Signifor (pasireotide diaspartate) MHIMedicaid · IL, MS2Original policy ↗
Siliq (brodalumab) MHIMedicaid · IL, MS—Original policy ↗
Simponi/Simponi Aria (golimumab) MHIMedicaid · IL, MS1Original policy ↗
Sivextro (tedizolid) MHIMedicaid · MS1Original policy ↗
Skin and Soft Tissue Substitutes357 · Commercial, Medicaid392Original policy ↗
Skin and Soft Tissue Substitutes MEDICARE392Original policy ↗
Skyclarys (omaveloxolone) MHIMedicaid · IL, MS—Original policy ↗
Skyrizi (risankizumab-rzaa) MHIMedicaid · IL, MS1Original policy ↗
Skysona (elivaldogene autotemcel)Commercial, Medicaid3Original policy ↗
Sleep Apnea or Snoring (eXciteObstructive Sleep Apnea (OSA)): MEDICARE422b2Original policy ↗
Small Bowel Multivisceral TransplantationCommercial, Medicaid24Original policy ↗
Smart Watch Photoplethysmography (PPG) for Detection of Atrial Fibrillation341 · Commercial6Original policy ↗
Sodium Oxybate (Lumryze, Xyrem, Xywav) MHIMedicaid · IL, MS—Original policy ↗
Sohonos (palvarotene) MHIMedicaid · MS—Original policy ↗
Soliris (eculizumab), Ultomiris (ravulizumab) and Biosimilars MHIMedicaid · IL, MS4Original policy ↗
Sotyktu (deucravacitinib) MHIMedicaid · IL, MS—Original policy ↗
Specimen Validity TestingEffective Aug 29, 2025 · Commercial12Original policy ↗
Specimen Validity TestingEffective Sep 8, 2023 · Medicaid8Original policy ↗
Speech Generating DevicesCommercial, Medicaid13Original policy ↗

Back to Molina Healthcare of Mississippi

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.